HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/24/2026ACC: 0001193125-26-177470
Officer· SVP, Chief Accounting Officer
Since Mar 2026
+27.59K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
27.59K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.24K
Price / share
—
Trade value
—
% of position
41.6%
4/22/2026
48.67K→68.91K
Total
Net shares
+20.24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2026 | A · Award | +20.24K | — | — | 41.6% | 48.67K | 68.91K |
| Total | +20.24K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.35K shares
Shares
+7.35K
Strike price
24.61
Held after
7.35K
Exercisable
—
4/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.35K shares | 4/22/2026 | A · Award | +7.35K | 24.61 | — | 7.35K |